Ivermectin Orifarm (Ivermectin)

Ivermectin binds to glutamate‑gated chloride channels that are present in the nerve and muscle cells of many parasites. This binding opens the channels, allowing an influx of chloride ions, which hyperpolarizes the cells, causing paralysis and eventual death of the parasite while sparing human cells.

The dosage of Ivermectin Orifarm is determined by the prescribing clinician based on the specific infection, patient weight, age, and clinical condition. Healthcare professionals follow established guidelines and adjust the regimen to achieve optimal therapeutic outcomes.

Safety data for ivermectin in pregnancy are limited, so it should only be used when the potential benefit justifies any possible risk to the fetus. During breastfeeding, the decision should consider the benefit to the mother versus potential exposure to the infant through breast milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ivermectin offers a broad spectrum of activity against many nematodes and ectoparasites, often with a single dose regimen, which can be advantageous over drugs requiring multiple daily doses. Compared with alternatives such as albendazole or praziquantel, ivermectin may have a different safety profile and is preferred for specific infections like onchocerciasis and scabies.

Ivermectin Orifarm should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight and extreme heat to maintain potency throughout its shelf life.

Ivermectin Orifarm is taken orally, usually as a single tablet or as directed by a healthcare professional. The tablet should be swallowed whole with water, and the exact timing relative to meals depends on the prescriber’s instructions.

Serious adverse events, though rare, can include severe skin reactions such as Stevens‑Johnson syndrome, neurological complications like seizures or encephalopathy, and significant liver injury. Patients should seek immediate medical attention if they experience rash, swelling, difficulty breathing, or neurological symptoms.

Ivermectin Orifarm is contraindicated in individuals with known hypersensitivity to ivermectin or any of its excipients. Caution is also advised for patients with severe liver disease, those taking strong CYP3A4 inhibitors, and pregnant women unless the therapeutic benefit outweighs potential risks.